Agilent Technologies Stock Fair Value – Agilent Technologies Outperforms Market Despite Dip, Gains +0.91%
July 28, 2023
🌧️Trending News
Agilent Technologies ($NYSE:A), a global leader in life sciences, diagnostics, and analytical instruments, recently showed strong performance despite a dip in the market. The company’s stock closed at $128.47, up 0.91% from the previous day and outperforming the S&P 500’s 0.77% increase. This gain is a testament to the strength of the company and its resilience in the face of a challenging market. Agilent Technologies is a leading provider of products and services that help customers solve problems in life sciences, diagnostics, and applied chemical markets. The company manufactures a wide range of products, services, and software including chromatography, mass spectrometry, electrical testing, and more. It also provides software for data analysis and storage. Agilent Technologies is dedicated to creating innovative solutions to meet the needs of their customer base, and this dedication has been reflected in their performance in spite of challenging market conditions.
In addition to their strong performance in the stock market, Agilent Technologies has demonstrated impressive results in other areas. The company recently launched new products that address customer needs in precision agriculture, data centers and automotive applications. They have also invested heavily in research and development, with plans to expand its portfolio of products and services. These investments have enabled Agilent Technologies to stay competitive and remain one of the top performers in the market. Overall, Agilent Technologies has shown resilience despite a dip in the market, closing up 0.91% and outperforming the S&P 500’s 0.77% increase. The company’s commitment to innovation and customer service has enabled it to remain competitive, demonstrating its ability to succeed even in challenging market conditions.
Analysis – Agilent Technologies Stock Fair Value
At GoodWhale, we conducted an analysis of AGILENT TECHNOLOGIES‘s wellbeing. After a thorough evaluation, we determined that the intrinsic value of AGILENT TECHNOLOGIES share is around $150.6, calculated by our proprietary Valuation Line. We believe this is a fair value for the stock, however, at the current market price of $126.7, AGILENT TECHNOLOGIES is undervalued by 15.9%. We strongly encourage investors to take advantage of this opportunity and consider AGILENT TECHNOLOGIES as a great investment. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Agilent Technologies. More…
| Total Revenues | Net Income | Net Margin |
| 7.04k | 1.35k | 19.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Agilent Technologies. More…
| Operations | Investing | Financing |
| 1.47k | -364 | -1.11k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Agilent Technologies. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 10.79k | 5.01k | 18.95 |
Key Ratios Snapshot
Some of the financial key ratios for Agilent Technologies are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 10.4% | 28.8% | 24.6% |
| FCF Margin | ROE | ROA |
| 16.8% | 19.0% | 10.0% |
Peers
The company has a strong presence in the market and competes with Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, and other companies. Agilent Technologies Inc. is committed to providing innovative products and services that meet the needs of customers and enable them to achieve their research goals.
– Qiagen NV ($NYSE:QGEN)
Qiagen is a Dutch company that provides molecular diagnostic solutions, including kits and instruments for sample preparation and real-time PCR. The company has a market cap of 9.99B as of 2022 and a ROE of 13.07%.
– Thermo Fisher Scientific Inc ($NYSE:TMO)
Thermo Fisher Scientific Inc is a biotechnology company that manufactures and sells scientific instruments, reagents, and laboratory products. The company has a market capitalization of 201.37 billion as of 2022 and a return on equity of 12.43%. Thermo Fisher Scientific is a global leader in serving science, with revenues of more than $30 billion and a workforce of more than 70,000 employees. The company’s mission is to enable its customers to make the world healthier, cleaner, and safer.
– Illumina Inc ($NASDAQ:ILMN)
Illumina Inc. is an American company headquartered in San Diego, California. It is a provider of sequencing and array-based solutions for genetic analysis. The company has a market cap of $36.65 billion as of 2022 and a return on equity of 0.28%. Illumina’s products are used by academic and commercial researchers in a variety of fields, including cancer, infectious disease, genetics, and more.
Summary
Agilent Technologies, a publicly traded company, has seen its share price rise in the latest trading session despite a dip in the overall market. The stock closed at $128.47, up 0.91%, outperforming the S&P 500 index. Analysts believe this is due to the company’s strong fundamentals and the large potential for long-term growth. Investors are advised to keep an eye on the company, as well as watch for developments in the market that may further boost Agilent’s performance.
It is essential to note the company’s potential risks and be aware of any negative news which could cause a sharp drop in share price. All in all, Agilent Technologies is a good stock to watch as it has considerable growth prospects for investors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
